FDA broadens existing emergency use of Lilly and Incytes baricitinib in patients hospitalized with COVID-19 requiring oxygen

Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today the U.S. Food and Drug Administration (FDA) has broadened the Emergency Use Authorization (EUA) for baricitinib to allow for ...